Free Trial
CVE:MPH

Medicure (MPH) Stock Price, News & Analysis

C$1.08
+0.08 (+8.00%)
(As of 07/24/2024 05:27 PM ET)
Today's Range
C$1.07
C$1.15
50-Day Range
C$1.00
C$1.25
52-Week Range
C$0.92
C$1.80
Volume
15,100 shs
Average Volume
4,803 shs
Market Capitalization
C$11.28 million
P/E Ratio
N/A
Dividend Yield
2.24%
Price Target
N/A
MPH stock logo

About Medicure Stock (CVE:MPH)

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

MPH Stock Price History

MPH Stock News Headlines

MPH:CA Medicure Inc.
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
See More Headlines
Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/24/2017
Today
7/26/2024
Next Earnings (Estimated)
7/26/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$1.08 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$21.69 million
Cash Flow
C$0.43 per share
Book Value
C$1.91 per share

Miscellaneous

Free Float
N/A
Market Cap
C$11.28 million
Optionable
Not Optionable
Beta
1.01
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Albert David Friesen Ph.D. (Age 77)
    Founder, CEO & Chairman of the board
    Comp: $232.2k
  • Dr. Neil Owens Ph.D.
    President & COO
  • Mr. Haaris Uddin B.Com.
    CPA, Chief Financial Officer
  • Dr. Reuben Saba Ph.D.
    Vice President of Scientific & Medical Affairs

MPH Stock Analysis - Frequently Asked Questions

How have MPH shares performed this year?

Medicure's stock was trading at C$1.40 at the start of the year. Since then, MPH stock has decreased by 22.9% and is now trading at C$1.08.
View the best growth stocks for 2024 here
.

How were Medicure's earnings last quarter?

Medicure Inc. (CVE:MPH) posted its quarterly earnings results on Wednesday, May, 24th. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of $0.04 by $0.37. The firm had revenue of $8.71 million for the quarter, compared to the consensus estimate of $14.50 million. Medicure had a negative trailing twelve-month return on equity of 4.51% and a negative net margin of 4.25%.

How do I buy shares of Medicure?

Shares of MPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Medicure own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicure investors own include Dollarama (DOL), Alimentation Couche-Tard (ATD.B), Canoe EIT Income Fund (ENDTF), ProMetic Life Sciences (PLI), Hudbay Minerals (HBM), Allena Pharmaceuticals (ALNA) and Ampliphi Biosciences (APHB).

This page (CVE:MPH) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners